Further to its earlier intimations dated October 14, 2025, and November 16, 2025. Thyrocare Technologies has informed that, the Stakeholders Relationship Committee of the Board of Directors of the Company, at its meeting held today December 1, 2025, has approved and allotted 10,61,07,794 equity shares of Rs. 10/- each as fully paid-up bonus equity shares, in the proportion of 2:1, i.e., 2 new fully paid-up equity shares of Rs. 10/- each for every 1 existing fully paid-up equity share of Rs. 10/- each, to the eligible members of the Company whose names appeared in the Register of Members / Register of the Beneficial Owners, as on November 28, 2025, the ‘Record Date’ fixed for this purpose. Consequent to the aforesaid allotment, the paid-up Equity Share capital of the Company has increased from 53,05,38,970 to 1,59,16,16,910. The Bonus Equity Shares shall rank in all respect with the existing fully paid-up Equity Shares of the Company. The meeting of the Stakeholders Relationship Committee concluded at 8.40 am (IST). This intimation is also available on the website of the Company at https://investor.thyrocare.com/.
The above information is a part of company’s filings submitted to BSE.
